Vetbiologics’ regenerative medicine technologies are designed, implemented and produced according to the highest standards. Vetbiologics follows the FDA guidelines for human cellular therapy production which means each product produced must be validated and must pass stringent criteria.
The Vetbiologics cell isolation process has been designed by leading stem cell scientists and implemented in a manner consistent with FDA guidelines. All Vetbiologics kits are manufactured according to the FDA Current Good Manufacturing Practices (cGMP) standards. Vetbiologics utilizes high quality reagents that are consistently screened by stem cell scientists to ensure the highest yield of regenerative cells per tissue sample.
Vetbiologics also has a state-of-the-art cGMP laboratory that is registered with the FDA as a tissue bank establishment. The Vetbiologics manufacturing process for ex-vivo cultured MSC’s also follows FDA guidelines. For stem cell banking, testing including counts and viability is performed on every sample to demonstrate suitability for transplantation.